Comprehensive Cell Solutions (CCS), a business unit of New York Blood Center Enterprises (NYBCe), announced today the grand opening of its GMP facility, located on the campus of the University of Louisville Medical Center, that will bolster the company’s cell and gene manufacturing capabilities within the regional and national life sciences ecosystem. With the NYBCe President and CEO Christopher D. Hillyer, MD, CCS leadership, and local University of Louisville dignitaries all in attendance, the ribbon-cutting ceremony, facility tour, and open house symbolizes unprecedented access to end-to-end cell therapy manufacturing capabilities.
New York Blood Center Enterprises Celebrates the Expansion of Cell & Gene Therapy GMP Manufacturing Capabilities at the Grand Opening of Louisville, Kentucky Site
